News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ascendancy Healthcare Announces Multi-Year Clinical Development Collaboration in China With Quintiles, Inc. (QTRN)


7/25/2013 9:51:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Ascendancy Healthcare, Inc. dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, announced today a multi-year collaboration with Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services. Under the terms of the agreement, Quintiles will provide product assessments, clinical research services, including trial planning, productivity optimization, and execution of cost-efficient studies, for therapeutic compounds Ascendancy in-licenses for development and commercialization in China and other Asian markets.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES